Clin2
NCT07658560Possibly a fitRecruiting

Weight loss pill study for overweight or obese adults without diabetes

Overweight or Obese Participants Without Diabetes

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old and are Chinese.
  • You are overweight (BMI 24-28) with a related condition like prediabetes, high blood pressure, or joint pain, or you are obese (BMI 28 or higher).
  • You have been trying to lose weight with diet and exercise for at least 3 months, with your weight staying stable (less than 5% change).
  • You are willing to continue your current diet and exercise plan during the study.
  • You are not diabetic and have no history of diabetes.
  • You have not used weight-loss drugs or certain other medications in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07809945Not yet recruiting· Phase 1
Weight loss study for people with overweight or obesity

This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.

Beijing, Beijing Municipality
NCT07784699Recruiting· Phase 1
Testing an experimental pill for weight loss in healthy or overweight adults

This study tests an experimental pill (GZC8072) for weight loss. It is a phase 1 trial, meaning it is one of the first times the drug is given to people, and the focus is on safety and how the body handles it. You would receive either a single dose (if you are healthy) or multiple doses (if you are overweight or obese) to see how the medication works.

Beijing
NCT07845513Not yet recruiting· Phase 1
Study of a new weight-loss medicine in Chinese adults

This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.

Beijing, Beijing Municipality
NCT07793019Recruiting· Phase 1
Weight loss and safety study in overweight adults

This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.

Beijing, Beijing Municipality
NCT07628127Recruiting· Phase 1
Weight loss pill study for adults with excess weight

This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.

Brisbane
NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai

Hear when a new Overweight or Obese Participants Without Diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.